Contactez-nous
À propos de la société
Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
US
Inconnue
Entreprise non vérifiée
Transparence commerciale
- Informations sur l'entreprise non vérifiées
- Demandez à leurs clients des avis
- N'a pas répondu aux avis négatifs